INNOSCIENCE (02577) saw its shares rise more than 5% during afternoon trading. At the time of writing, the stock was up 4.8%, trading at HK$57.85 with a turnover of HK$289 million. The movement follows the company's announcement that it has received a filing notice from the China Securities Regulatory Commission regarding the full circulation of its H-shares. According to the notice, 35 shareholders have been granted approval to convert approximately 374 million domestic unlisted shares, representing 40.85% of the total share capital, into H-shares for listing and trading on the Main Board of the Hong Kong Stock Exchange. Upon completion, INNOSCIENCE's H-share capital will surge to approximately 899 million shares, accounting for over 98% of the total. In a related development, Bank of America Securities issued a report noting that INNOSCIENCE's management, during a post-earnings analyst briefing for the 2025 fiscal year, indicated strong downstream demand for 2026, driven by increasing adoption of Gallium Nitride (GaN) across various end markets. Management forecasts total revenue for the 2026 fiscal year to reach between RMB 2 billion and RMB 2.5 billion, representing year-on-year growth of 65% to 106%, with gross margin expected to further improve to above 15%.